LD-2 disclosure · 4th Quarter - Report
MEMSEL, INC.
Client
- Name
- MEMSEL, INC.
- Description
- Scientific research & development company
- Location
- Texas · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Monitor Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Public Law 118-159, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP
Defense
Monitor Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Public Law 118-159, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP
Health Issues
Monitor Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 Public Law 118-159, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP